IBDEI15I ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20567,1,3,0)
 ;;=3^Ranitidine Hydrochl Inj 25mg
 ;;^UTILITY(U,$J,358.3,20568,0)
 ;;=J2820^^116^1243^84^^^^1
 ;;^UTILITY(U,$J,358.3,20568,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20568,1,1,0)
 ;;=1^J2820
 ;;^UTILITY(U,$J,358.3,20568,1,3,0)
 ;;=3^Sargramostim Inj 250mcg
 ;;^UTILITY(U,$J,358.3,20569,0)
 ;;=J7050^^116^1243^70^^^^1
 ;;^UTILITY(U,$J,358.3,20569,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20569,1,1,0)
 ;;=1^J7050
 ;;^UTILITY(U,$J,358.3,20569,1,3,0)
 ;;=3^Normal Saline 250cc
 ;;^UTILITY(U,$J,358.3,20570,0)
 ;;=J9015^^116^1243^3^^^^1
 ;;^UTILITY(U,$J,358.3,20570,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20570,1,1,0)
 ;;=1^J9015
 ;;^UTILITY(U,$J,358.3,20570,1,3,0)
 ;;=3^Aldesleukin Inj Single Vial
 ;;^UTILITY(U,$J,358.3,20571,0)
 ;;=J9020^^116^1243^6^^^^1
 ;;^UTILITY(U,$J,358.3,20571,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20571,1,1,0)
 ;;=1^J9020
 ;;^UTILITY(U,$J,358.3,20571,1,3,0)
 ;;=3^Asparaginase Inj 10,000 Units
 ;;^UTILITY(U,$J,358.3,20572,0)
 ;;=J9050^^116^1243^17^^^^1
 ;;^UTILITY(U,$J,358.3,20572,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20572,1,1,0)
 ;;=1^J9050
 ;;^UTILITY(U,$J,358.3,20572,1,3,0)
 ;;=3^Carmustine Inj 100mg
 ;;^UTILITY(U,$J,358.3,20573,0)
 ;;=J9065^^116^1243^20^^^^1
 ;;^UTILITY(U,$J,358.3,20573,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20573,1,1,0)
 ;;=1^J9065
 ;;^UTILITY(U,$J,358.3,20573,1,3,0)
 ;;=3^Cladribine Inj 1mg
 ;;^UTILITY(U,$J,358.3,20574,0)
 ;;=J9098^^116^1243^24^^^^1
 ;;^UTILITY(U,$J,358.3,20574,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20574,1,1,0)
 ;;=1^J9098
 ;;^UTILITY(U,$J,358.3,20574,1,3,0)
 ;;=3^Cytarabine Liposome Inj 10mg
 ;;^UTILITY(U,$J,358.3,20575,0)
 ;;=J9120^^116^1243^26^^^^1
 ;;^UTILITY(U,$J,358.3,20575,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20575,1,1,0)
 ;;=1^J9120
 ;;^UTILITY(U,$J,358.3,20575,1,3,0)
 ;;=3^Dactinomycin Inj 0.5mg
 ;;^UTILITY(U,$J,358.3,20576,0)
 ;;=J9130^^116^1243^25^^^^1
 ;;^UTILITY(U,$J,358.3,20576,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20576,1,1,0)
 ;;=1^J9130
 ;;^UTILITY(U,$J,358.3,20576,1,3,0)
 ;;=3^Dacarbazine Inj 100mg
 ;;^UTILITY(U,$J,358.3,20577,0)
 ;;=J9150^^116^1243^28^^^^1
 ;;^UTILITY(U,$J,358.3,20577,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20577,1,1,0)
 ;;=1^J9150
 ;;^UTILITY(U,$J,358.3,20577,1,3,0)
 ;;=3^Daunorubicin Inj 10mg
 ;;^UTILITY(U,$J,358.3,20578,0)
 ;;=J9165^^116^1243^32^^^^1
 ;;^UTILITY(U,$J,358.3,20578,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20578,1,1,0)
 ;;=1^J9165
 ;;^UTILITY(U,$J,358.3,20578,1,3,0)
 ;;=3^Diethylstilbestrol Inj 250mg
 ;;^UTILITY(U,$J,358.3,20579,0)
 ;;=J9170^^116^1243^34^^^^1
 ;;^UTILITY(U,$J,358.3,20579,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20579,1,1,0)
 ;;=1^J9170
 ;;^UTILITY(U,$J,358.3,20579,1,3,0)
 ;;=3^Docetaxel Inj 20mg
 ;;^UTILITY(U,$J,358.3,20580,0)
 ;;=J9200^^116^1243^40^^^^1
 ;;^UTILITY(U,$J,358.3,20580,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20580,1,1,0)
 ;;=1^J9200
 ;;^UTILITY(U,$J,358.3,20580,1,3,0)
 ;;=3^Floxuridine Inj 500mg
 ;;^UTILITY(U,$J,358.3,20581,0)
 ;;=J9211^^116^1243^48^^^^1
 ;;^UTILITY(U,$J,358.3,20581,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20581,1,1,0)
 ;;=1^J9211
 ;;^UTILITY(U,$J,358.3,20581,1,3,0)
 ;;=3^Idarubicin HCL Inj 5mg
 ;;^UTILITY(U,$J,358.3,20582,0)
 ;;=J9215^^116^1243^50^^^^1
 ;;^UTILITY(U,$J,358.3,20582,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20582,1,1,0)
 ;;=1^J9215
 ;;^UTILITY(U,$J,358.3,20582,1,3,0)
 ;;=3^Interferon Alfa-N3 Inj 250,000IU
 ;;^UTILITY(U,$J,358.3,20583,0)
 ;;=J9216^^116^1243^51^^^^1
 ;;^UTILITY(U,$J,358.3,20583,1,0)
 ;;=^358.31IA^3^2
